Showing results (41-50 of 285) with videos related to

Sort By:
Pageof 29
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2013
The role of HBsAg quantification for monitoring natural history and treatment outcomeMichelle Martinot-Peignoux, Martine Lapalus, Tarik Asselah, et al.
Gastroenterologie Clinique Et Biologique|October 30, 2007
[HCV non-responder patients: definition of non-response and treatment strategy]Patrick Marcellin, Marc Bourlière, Jean-Michel Pawlotsky, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2016
Direct-acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN-free treatment and future perspectivesTarik Asselah, Nathalie Boyer, David Saadoun, et al.
Seminars in Liver Disease|February 14, 2007
Genetics, genomics, and proteomics: implications for the diagnosis and the treatment of chronic hepatitis CTarik Asselah, Ivan Bièche, Valérie Paradis, et al.
Clinics in Liver Disease|November 6, 2007
Interferon therapy for chronic hepatitis BTarik Asselah, Olivier Lada, Rami Moucari, et al.
Viruses|April 23, 2022
Staging Fibrosis in Chronic Viral HepatitisAna Carolina Cardoso, Claudio Figueiredo-Mendes, Cristiane A Villela-Nogueira, et al.
European Journal of Gastroenterology & Hepatology|August 9, 2006
Hepatitis C virus eradication followed by HBeAg to anti-HBe seroconversion after pegylated interferon-alpha2b plus ribavirin treatment in a patient with hepatitis B and C coinfectionPierre-Emmanuel Rautou, Tarik Asselah, David Saadoun, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 8, 2006
The current status of antiviral therapy of chronic hepatitis BTarik Asselah, Marie-Pierre Ripault, Corinne Castelnau, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 15, 2009
Clinical performances of two real-time PCR assays and bDNA/TMA to early monitor treatment outcome in patients with chronic hepatitis CMichelle Martinot-Peignoux, Hacène Khiri, Laurence Leclere, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 21, 2020
Future treatments for hepatitis delta virus infectionTarik Asselah, Dimitri Loureiro, Issam Tout, et al.
Pageof 29